All lobbying filings

DEXCOM, INC.

Lobbying for DEXCOM, INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $380,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 1

HR 1539
Medical Device Electronic Labeling Act

Lobbying activity 3

Health Issues

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking

Medicare/Medicaid

CGM Coverage policies Issues related to breakthrough technology

Trade (domestic/foreign)

Issues related to global supply chains Issues related to the Administration's Executive Orders

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.